Prospective observational study on indication, planning, technical implementation, and outcome of transarterial radioembolization (TARE) in malignant liver tumors

Recruiting

• Conditions: C22.0; C78.7; C22.1; Liver cell carcinoma; Secondary malignant neoplasm of liver and intrahepatic bile duct; Intrahepatic bile duct carcinoma

• Registration Number: DRKS00033168
• Lead Sponsor: Klinik für Nuklearmedizin, Universitätsklinikum Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients for whom the indication for TARE was established in an interdisciplinary tumor board

Exclusion Criteria

Age less than 18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
hepatic progression free survival

Secondary Outcome Measures

Name	Time	Method
progression free survival, overall survival, complication rate